This brand name is authorized in Nigeria.
The drug BONDOMET contains one active pharmaceutical ingredient (API):
1
|
UNII
56LH93261Y - METHYLDOPA
|
|
Methyldopa is an antihypertensive agent acting centrally by stimulating alpha adrenergic receptors. |
|
This drug has been approved in Nigeria as follows:
| Identifier | Form | Presentation | Description | Approval |
|---|---|---|---|---|
| 04-8442 | Tablet | Bondomet Tablet TAB 250 mg 10 x 10's (in blisters) | Yellowish, 10.7 mm, round and convex, embossed on one side with “B’DOMET” and on the other side with Bond logo | 27/06/2024 |
This drug has been assigned below unique identifiers within the countries it is being marketed:
| Country | Identification scheme | Identifier(s) |
|---|---|---|
| NG | Registered Drug Product Database | 04-8442 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.